{
    "ticker": "GOVX",
    "name": "GeoVax Labs, Inc.",
    "description": "GeoVax Labs, Inc. is a biotechnology company focused on the development of innovative vaccines and immunotherapies for infectious diseases and cancer. Founded in 2001 and headquartered in Atlanta, Georgia, GeoVax utilizes its proprietary vaccine platform to create safe and effective solutions that address unmet medical needs. The company\u2019s lead product candidate, GEO-CM04S1, is a COVID-19 vaccine designed to provide broad protection against variants of the virus, showcasing GeoVax's commitment to addressing current global health challenges. In addition to its COVID-19 efforts, GeoVax is advancing other vaccines targeting diseases such as HIV and various cancers, leveraging its expertise in viral vector technology. The company\u2019s research is supported by collaborations with leading academic institutions and government agencies, aiming to bring novel therapeutic options to patients. As a participant in the rapidly evolving biotech sector, GeoVax is positioned at the forefront of vaccine research and development, striving to contribute to global health security through its cutting-edge innovations.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Atlanta, Georgia, USA",
    "founded": "2001",
    "website": "https://www.geovax.com",
    "ceo": "David D. W. R. Dyer",
    "social_media": {
        "twitter": "https://twitter.com/geovaxlabs",
        "linkedin": "https://www.linkedin.com/company/geovax-labs-inc/"
    },
    "investor_relations": "https://www.geovax.com/investor-relations",
    "key_executives": [
        {
            "name": "David D. W. R. Dyer",
            "position": "CEO"
        },
        {
            "name": "Harold D. S. F. G. G. DeMeyer",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Vaccines",
            "products": [
                "GEO-CM04S1 (COVID-19 Vaccine)",
                "HIV Vaccine Candidates"
            ]
        },
        {
            "category": "Immunotherapies",
            "products": [
                "Cancer Immunotherapy Candidates"
            ]
        }
    ],
    "seo": {
        "meta_title": "GeoVax Labs, Inc. | Innovative Vaccines and Immunotherapies",
        "meta_description": "GeoVax Labs, Inc. is dedicated to developing innovative vaccines and immunotherapies for infectious diseases and cancer, including a COVID-19 vaccine. Learn more about their mission and products.",
        "keywords": [
            "GeoVax",
            "Vaccines",
            "Immunotherapy",
            "COVID-19",
            "HIV",
            "Cancer",
            "Biotechnology"
        ]
    },
    "faq": [
        {
            "question": "What does GeoVax specialize in?",
            "answer": "GeoVax specializes in developing innovative vaccines and immunotherapies for infectious diseases and cancer."
        },
        {
            "question": "What is GeoVax's lead product?",
            "answer": "GeoVax's lead product is GEO-CM04S1, a COVID-19 vaccine."
        },
        {
            "question": "Where is GeoVax headquartered?",
            "answer": "GeoVax is headquartered in Atlanta, Georgia, USA."
        },
        {
            "question": "When was GeoVax founded?",
            "answer": "GeoVax was founded in 2001."
        }
    ],
    "competitors": [
        "MRNA",
        "NVAX",
        "BNTX",
        "PFE"
    ],
    "related_stocks": [
        "JNJ",
        "AZN",
        "REGN",
        "GILD"
    ]
}